Qurgen
PrivateLast Round
VC Round
Jan 1, 2023
Total Funding Raised
$4M
Company Overview
Qurgen is a biotechnology company that develops protein-based regenerative medicine and transcription factor drugs to treat cancer, heart failure, diabetes, and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qurgen Comparables
Compare Qurgen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stemgenics, Inc. | 78% | |
| Reprogram Biosciences | 76% | |
| Asgard Therapeutics | 76% |
Qurgen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 1, 2023 |
Qurgen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 70% MoM.
- Jan 1, 2023
$55M raised in a VC Round.
Qurgen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qurgen's valuation, stock price, and market status.
Is Qurgen a public or private company?
Qurgen is a private company.
What is the current stock price of Qurgen?
Qurgen is a private company with no public stock price. No recent secondary market data is available.
How much is Qurgen worth (valuation)?
Valuation information for Qurgen is not publicly available.
Can I buy Qurgen stock?
Qurgen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qurgen's last funding round?
Qurgen's most recent funding round was VC Round on January 1, 2023.
Who are the main investors in Qurgen?
Key investors in Qurgen include NIH RADx.
Will Qurgen IPO soon?
No public IPO plans have been announced for Qurgen.
How can I track Qurgen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qurgen's secondary market activity and sign up for updates.